Skip to main content
Erschienen in: Endocrine 1/2022

07.08.2021 | Original Article

Chronic asthenia in patients who have undergone endocrine neck surgery

verfasst von: Gregorio Scerrino, Giuseppina Melfa, Daniela Lo Brutto, Sergio Mazzola, Alessandro Corigliano, Irene Vitale, Roberta Tutino, Giulia Rotolo, Giuseppina Orlando, Gianfranco Cocorullo

Erschienen in: Endocrine | Ausgabe 1/2022

Einloggen, um Zugang zu erhalten

Abstract

Introduction

The impact of chronic asthenia after thyroidectomy has been evaluated in two previous studies comparing total thyroidectomy and hemithyroidectomy. We compared its impact on patients undergoing thyroidectomy, parathyroidectomy for primary hyperparathyroidism, and cholecystectomy.

Methods

Patients recruited for surgery (233 consecutive total thyroidectomies for non-toxic multinodular goiter, Group I, 43 consecutive parathyroidectomies for primary hyperparathyroidism, group II and a sample of 43 laparoscopic cholecystectomies, group III) were compared at three times: pre-operative, 6 months after surgery, 1 year after surgery. A brief fatigue inventory (BFI) was administered to assess asthenia. We excluded intermediate or high-risk thyroid carcinomas, Grave’s disease, obese patients, secondary and tertiary hyperparathyroidism, vitamin D deficiency, and acute cholecystitis. In the postoperative period, patients who had undergone complications of each surgical procedure were also excluded. Demographics, smoking, alcohol abuse, chronic diseases (renal, cardiac, pulmonary, hepatic, and diabetes mellitus), anxiety and depression were noted.

Results

In Group I the significant increase of asthenia during the three periods of detection (p < 0.001) was confirmed. Renal failure further increased the risk of asthenia. In Group II, asthenia after 6 months and 1 year after surgery decreased significantly (p < 0.001). In Group III, the variations in BFI during the three periods were not significant.

Conclusions

Asthenia is a frequent sequela of total thyroidectomy, also in comparison with other types of surgery. Patients undergoing thyroidectomy must be informed of the possible implications of surgery, which should be calibrated on the strict application of guidelines.
Literatur
1.
Zurück zum Zitat K.A. Donovan, P.B. Jacobsen, The Fatigue Symptom Inventory: a systematic review of its psychometric properties. Support Care Cancer 19, 169–185 (2011) K.A. Donovan, P.B. Jacobsen, The Fatigue Symptom Inventory: a systematic review of its psychometric properties. Support Care Cancer 19, 169–185 (2011)
2.
Zurück zum Zitat C.D. Adkisson, L. Yip, M.J. Armstrong, M.T. Stang, S.E. Carty, K.L. McCoy, Fibromyalgia symptoms and medication requirements respond to parathyroidectomy. Surgery 156(6), 1614–1621 (2014)PubMed C.D. Adkisson, L. Yip, M.J. Armstrong, M.T. Stang, S.E. Carty, K.L. McCoy, Fibromyalgia symptoms and medication requirements respond to parathyroidectomy. Surgery 156(6), 1614–1621 (2014)PubMed
4.
Zurück zum Zitat J.H. Friedman, R.G. Brown, C. Comella et al. Working Group on Fatigue in Parkinson’s Disease. Fatigue in Parkinson’s disease. Mov. Disord. 22(3), 297–308 (2007)PubMed J.H. Friedman, R.G. Brown, C. Comella et al. Working Group on Fatigue in Parkinson’s Disease. Fatigue in Parkinson’s disease. Mov. Disord. 22(3), 297–308 (2007)PubMed
6.
Zurück zum Zitat M.P. Davis, D. Walsh, Mechanisms of fatigue. J. Support Oncol. 8(4), 164–174 (2010)PubMed M.P. Davis, D. Walsh, Mechanisms of fatigue. J. Support Oncol. 8(4), 164–174 (2010)PubMed
7.
Zurück zum Zitat M. Gonzàlez-Izal, A. Malanda, E. Gorostiaga, M. Izquierdo, Electromyographic models to assess muscle fatigue. J. Electromyogr. Kinesiol. 22(4), 501–512 (2012)PubMed M. Gonzàlez-Izal, A. Malanda, E. Gorostiaga, M. Izquierdo, Electromyographic models to assess muscle fatigue. J. Electromyogr. Kinesiol. 22(4), 501–512 (2012)PubMed
8.
Zurück zum Zitat B.M. Kluger, L.B. Krupp, R.M. Enoka, Fatigue and fatigability in neurologic illnesses: proposal for a unified taxonomy. Neurology 80(4), 409–416 (2013)PubMedPubMedCentral B.M. Kluger, L.B. Krupp, R.M. Enoka, Fatigue and fatigability in neurologic illnesses: proposal for a unified taxonomy. Neurology 80(4), 409–416 (2013)PubMedPubMedCentral
9.
Zurück zum Zitat A. Glaus, R. Crow, S.A. Hammond, Qualitative study to explore the concept of fatigue/tiredness in cancer patients and in healthy individuals. Support Care Cancer 4, 82–96 (1996)PubMed A. Glaus, R. Crow, S.A. Hammond, Qualitative study to explore the concept of fatigue/tiredness in cancer patients and in healthy individuals. Support Care Cancer 4, 82–96 (1996)PubMed
10.
Zurück zum Zitat D.M. Irvine, L. Vincent, N. Bubela, L. Thompson, J.E. Graydon, A critical appraisal of the research literature investigating fa- tigue in the individual with cancer. Cancer Nurs. 14(4), 188–199 (1991)PubMed D.M. Irvine, L. Vincent, N. Bubela, L. Thompson, J.E. Graydon, A critical appraisal of the research literature investigating fa- tigue in the individual with cancer. Cancer Nurs. 14(4), 188–199 (1991)PubMed
11.
Zurück zum Zitat S. Kelley, Endocrinology update: thyroid disorders. FP Essent. 451, 11–16 (2016) S. Kelley, Endocrinology update: thyroid disorders. FP Essent. 451, 11–16 (2016)
13.
Zurück zum Zitat E.S. van der Valk, L.C. Smans, H. Hofstetter, J.H. Stubbe, M. de Vries, F.J. Backx, A.R. Hermus, P.M. Zelissen, Decreased physical activity, reduced QoL and presence of debilitating fatigue in patients with Addison’s disease. Clin. Endocrinol. 85(3), 354–360 (2016). https://doi.org/10.1111/cen.13059CrossRef E.S. van der Valk, L.C. Smans, H. Hofstetter, J.H. Stubbe, M. de Vries, F.J. Backx, A.R. Hermus, P.M. Zelissen, Decreased physical activity, reduced QoL and presence of debilitating fatigue in patients with Addison’s disease. Clin. Endocrinol. 85(3), 354–360 (2016). https://​doi.​org/​10.​1111/​cen.​13059CrossRef
14.
Zurück zum Zitat L. Rosato, F. Pacini, S.L. Panier, G. Mondini, A. Ginardi, M. Maggio, M.C. Bosco, Della Pepa: post-thyroidectomy chronic asthenia: self-deception or disease? Endocrine 48, 615–620 (2015)PubMed L. Rosato, F. Pacini, S.L. Panier, G. Mondini, A. Ginardi, M. Maggio, M.C. Bosco, Della Pepa: post-thyroidectomy chronic asthenia: self-deception or disease? Endocrine 48, 615–620 (2015)PubMed
15.
Zurück zum Zitat G. Scerrino, G. Melfa, C. Raspanti, A. Attard, S. Mazzola, R. Gullo, S. Bonventre, M. Attard, G. Cocorullo, G. Gulotta, The prevalence of post-thyroidectomy chronic asthenia: a prospective cohort study. Langenbecks Arch. Surg. 402(7), 1095–1102 (2017)PubMed G. Scerrino, G. Melfa, C. Raspanti, A. Attard, S. Mazzola, R. Gullo, S. Bonventre, M. Attard, G. Cocorullo, G. Gulotta, The prevalence of post-thyroidectomy chronic asthenia: a prospective cohort study. Langenbecks Arch. Surg. 402(7), 1095–1102 (2017)PubMed
16.
Zurück zum Zitat WHO Obesity: preventing and managing the global epidemic. Report of WHO consultation. WHO technical report series 894. World Health Organization, Geneva (2000). WHO Obesity: preventing and managing the global epidemic. Report of WHO consultation. WHO technical report series 894. World Health Organization, Geneva (2000).
17.
Zurück zum Zitat G. Scerrino, G. Morfino, N.C. Paladino, V. Di Paola, E. Amodio, G. Gulotta, S. Bonventre, Does thyroid surgery for Graves’ disease improve health-related quality of life? Surg. Today 43(12), 1398–1405 (2013)PubMed G. Scerrino, G. Morfino, N.C. Paladino, V. Di Paola, E. Amodio, G. Gulotta, S. Bonventre, Does thyroid surgery for Graves’ disease improve health-related quality of life? Surg. Today 43(12), 1398–1405 (2013)PubMed
18.
Zurück zum Zitat American Diabetes Association, Diagnosis and classification of diabetes mellitus. Diabetes Care 33(Suppl. 1), s62–s69 (2010)PubMedCentral American Diabetes Association, Diagnosis and classification of diabetes mellitus. Diabetes Care 33(Suppl. 1), s62–s69 (2010)PubMedCentral
19.
Zurück zum Zitat C. Raphael, C. Briscoe, J. Davies, Z.I. Whinnett, C. Manisty, R. Sutton, J. Mayet, D.P. Francis, Limitations of the New York Heart Association functional classification system and self-reported walking distances in chronic heart failure. Heart 93, 476–482 (2007)PubMed C. Raphael, C. Briscoe, J. Davies, Z.I. Whinnett, C. Manisty, R. Sutton, J. Mayet, D.P. Francis, Limitations of the New York Heart Association functional classification system and self-reported walking distances in chronic heart failure. Heart 93, 476–482 (2007)PubMed
20.
Zurück zum Zitat R.A. Pauwels, A.S. Buist, P.M.A. Calverley, C.R. Jenkins, S.S. Hurd, Global strategy for the diagnosis, management, and preven- tion of chronic obstructive pulmonary disease. NHLBI/WHO Global initiative for chronic obstructive lung disease (GOLD). Workshop summary. Am. J. Respir. Crit. Care Med. 163, 1256–1276 (2001)PubMed R.A. Pauwels, A.S. Buist, P.M.A. Calverley, C.R. Jenkins, S.S. Hurd, Global strategy for the diagnosis, management, and preven- tion of chronic obstructive pulmonary disease. NHLBI/WHO Global initiative for chronic obstructive lung disease (GOLD). Workshop summary. Am. J. Respir. Crit. Care Med. 163, 1256–1276 (2001)PubMed
21.
Zurück zum Zitat F. Durand, D. Valla, Assessment of prognosis of cirrhosis. Semin. Liver Dis. 28(1), 110–122 (2008)PubMed F. Durand, D. Valla, Assessment of prognosis of cirrhosis. Semin. Liver Dis. 28(1), 110–122 (2008)PubMed
22.
Zurück zum Zitat C. Bauer, M.L. Melamed, T.H. Hostetter, Staging of chronic kidney disease: time for a course correction. J. Am. Soc. Nephrol. 19, 844–846 (2008)PubMed C. Bauer, M.L. Melamed, T.H. Hostetter, Staging of chronic kidney disease: time for a course correction. J. Am. Soc. Nephrol. 19, 844–846 (2008)PubMed
24.
Zurück zum Zitat D. Quattrone, M. Di Forti, C. Gayer-Anderson, L. Ferraro, H.E. Jongsma, G. Tripoli, C. La Cascia, D. La Barbera, I. Tarricone, D. Berardi, A. Szöke, C. Arango, A. Lasalvia, A. Tortelli, P.M. Llorca, L. de Haan, E. Velthorst, J. Bobes, M. Bernardo, J. Sanjuán, J.L. Santos, M. Arrojo, C.M. Del-Ben, P.R. Menezes, J.P. Selten, E.U.-G.E.I.W.P.2 Group, P.B. Jones, J.B. Kirkbride, A.L. Richards, M.C. O’Donovan, P.C. Sham, E. Vassos, B.P. Rutten, O.S.J. van, C. Morgan, C.M. Lewis, R.M. Murray, U. Reininghaus, Transdiagnostic dimensions of psychopathology at first episode psychosis: findings from the multinational EU-GEI study. Psychol. Med. 49(8), 1378–1391 (2019)PubMed D. Quattrone, M. Di Forti, C. Gayer-Anderson, L. Ferraro, H.E. Jongsma, G. Tripoli, C. La Cascia, D. La Barbera, I. Tarricone, D. Berardi, A. Szöke, C. Arango, A. Lasalvia, A. Tortelli, P.M. Llorca, L. de Haan, E. Velthorst, J. Bobes, M. Bernardo, J. Sanjuán, J.L. Santos, M. Arrojo, C.M. Del-Ben, P.R. Menezes, J.P. Selten, E.U.-G.E.I.W.P.2 Group, P.B. Jones, J.B. Kirkbride, A.L. Richards, M.C. O’Donovan, P.C. Sham, E. Vassos, B.P. Rutten, O.S.J. van, C. Morgan, C.M. Lewis, R.M. Murray, U. Reininghaus, Transdiagnostic dimensions of psychopathology at first episode psychosis: findings from the multinational EU-GEI study. Psychol. Med. 49(8), 1378–1391 (2019)PubMed
25.
Zurück zum Zitat R.L. Spitzer, K. Kroenke, J.B.W. Williams, B. Lowe, A brief measure for assessing generalized anxiety disorder. Arch. Intern. Med. 166, 1092–1097 (2006)PubMed R.L. Spitzer, K. Kroenke, J.B.W. Williams, B. Lowe, A brief measure for assessing generalized anxiety disorder. Arch. Intern. Med. 166, 1092–1097 (2006)PubMed
26.
27.
Zurück zum Zitat T.R. Mendoza, X.S. Wang, C.S. Cleeland, M. Morrissey, B.A. Johnson, J.K. Wendt, S.L. Huber, The rapid assessment of fatigue severity in cancer patients: use of the Brief Fatigue Inventory. Cancer 85(5), 1186–1196 (1999)PubMed T.R. Mendoza, X.S. Wang, C.S. Cleeland, M. Morrissey, B.A. Johnson, J.K. Wendt, S.L. Huber, The rapid assessment of fatigue severity in cancer patients: use of the Brief Fatigue Inventory. Cancer 85(5), 1186–1196 (1999)PubMed
28.
Zurück zum Zitat X. Huang, W. Zhou, Y. Zhang, Features of fatigue in patients with early-stage non-small cells lung cancer. J. Res. Med. Sci. 20, 268–272 (2015)PubMedPubMedCentral X. Huang, W. Zhou, Y. Zhang, Features of fatigue in patients with early-stage non-small cells lung cancer. J. Res. Med. Sci. 20, 268–272 (2015)PubMedPubMedCentral
29.
Zurück zum Zitat L.O. Farnebo, Primary hyperparathyroidism. Update on pathophysiology, clinical presentation and surgical treatment. Scand. J. Surg. 93, 282–287 (2004)PubMed L.O. Farnebo, Primary hyperparathyroidism. Update on pathophysiology, clinical presentation and surgical treatment. Scand. J. Surg. 93, 282–287 (2004)PubMed
31.
Zurück zum Zitat J.L. Pasieka, L.L. Parsons, L.J. Demeure, S. Wilson, P. Malycha, J. Johns, B. Krzywda, Patient-based 131313 surgical outcome tool demonstrating alleviation of symptoms following parathyroidectomy in patients with hyperparathyroidism. World J. Surg. 26, 942–949 (2002)PubMed J.L. Pasieka, L.L. Parsons, L.J. Demeure, S. Wilson, P. Malycha, J. Johns, B. Krzywda, Patient-based 131313 surgical outcome tool demonstrating alleviation of symptoms following parathyroidectomy in patients with hyperparathyroidism. World J. Surg. 26, 942–949 (2002)PubMed
32.
Zurück zum Zitat L.A. Mack, J.L. Pasieka, Asymptomatic primary hyperparathyroidism: a surgical perspective. Surg. Clin. N. Am. 84, 803–816 (2004)PubMed L.A. Mack, J.L. Pasieka, Asymptomatic primary hyperparathyroidism: a surgical perspective. Surg. Clin. N. Am. 84, 803–816 (2004)PubMed
33.
Zurück zum Zitat M.S. Eigelberger, W.K. Cheah, P.H. Ituarte, L. Streja, Q.Y. Duh, O.H. Clark, The NIH criteria for parathyroidectomy in asymptomatic primary hyperparathyroidism: are they too limited? Ann. Surg. 239(4), 528–535 (2004)PubMedPubMedCentral M.S. Eigelberger, W.K. Cheah, P.H. Ituarte, L. Streja, Q.Y. Duh, O.H. Clark, The NIH criteria for parathyroidectomy in asymptomatic primary hyperparathyroidism: are they too limited? Ann. Surg. 239(4), 528–535 (2004)PubMedPubMedCentral
34.
Zurück zum Zitat J.P. Bilezikian, M.L. Brandi, R. Eastell, S.J. Silverberg, R. Udelsman, C. Marcocci, J.T. Potts Jr, Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the Fourth International Workshop. J. Clin. Endocrinol. Metab. 99(10), 3561–3569 (2014)PubMedPubMedCentral J.P. Bilezikian, M.L. Brandi, R. Eastell, S.J. Silverberg, R. Udelsman, C. Marcocci, J.T. Potts Jr, Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the Fourth International Workshop. J. Clin. Endocrinol. Metab. 99(10), 3561–3569 (2014)PubMedPubMedCentral
35.
Zurück zum Zitat A.A. Khan, D.A. Hanley, R. Rizzoli, J. Bollerslev, J.E. Young, L. Rejnmark, R. Thakker, P. D’Amour, T. Paul, S. Van Uum, M.Z. Shrayyef, D. Goltzman, S. Kaiser, N.E. Cusano, R. Bouillon, L. Mosekilde, A.W. Kung, S.D. Rao, S.K. Bhadada, B.L. Clarke, J. Liu, Q. Duh, E.M. Lewiecki, F. Bandeira, R. Eastell, C. Marcocci, S.J. Silverberg, R. Udelsman, K.S. Davison, J.T. Potts Jr, M.L. Brandi, J.P. Bilezikian, Primary hyperparathyroidism: review and recommendations on evaluation, diagnosis, and management. A Canadian and International Consensus. Osteoporos. Int. 28(1), 1–19 (2017)PubMed A.A. Khan, D.A. Hanley, R. Rizzoli, J. Bollerslev, J.E. Young, L. Rejnmark, R. Thakker, P. D’Amour, T. Paul, S. Van Uum, M.Z. Shrayyef, D. Goltzman, S. Kaiser, N.E. Cusano, R. Bouillon, L. Mosekilde, A.W. Kung, S.D. Rao, S.K. Bhadada, B.L. Clarke, J. Liu, Q. Duh, E.M. Lewiecki, F. Bandeira, R. Eastell, C. Marcocci, S.J. Silverberg, R. Udelsman, K.S. Davison, J.T. Potts Jr, M.L. Brandi, J.P. Bilezikian, Primary hyperparathyroidism: review and recommendations on evaluation, diagnosis, and management. A Canadian and International Consensus. Osteoporos. Int. 28(1), 1–19 (2017)PubMed
36.
Zurück zum Zitat A.D. Demir, A review of parathyroid mass and patients with nonspecific complaints. J. Int. Med. Res. 48(1), 1–6 (2020) A.D. Demir, A review of parathyroid mass and patients with nonspecific complaints. J. Int. Med. Res. 48(1), 1–6 (2020)
37.
Zurück zum Zitat B.L. Solomon, M. Schaaf, R.C. Smallridge, Psychologic symptoms before and after parathyroid surgery. Am. J. Med. 96, 101–106 (1994)PubMed B.L. Solomon, M. Schaaf, R.C. Smallridge, Psychologic symptoms before and after parathyroid surgery. Am. J. Med. 96, 101–106 (1994)PubMed
38.
Zurück zum Zitat D.S. Rao, E.R. Phillips, G.W. Divine, G.B. Talpos, Randomized controlled clinical trial of surgery versus no surgery in pa- tients with mild asymptomatic primary hyperparathyroidism. J. Clin. Endocrinol. Metab. 89, 5415–5422 (2004)PubMed D.S. Rao, E.R. Phillips, G.W. Divine, G.B. Talpos, Randomized controlled clinical trial of surgery versus no surgery in pa- tients with mild asymptomatic primary hyperparathyroidism. J. Clin. Endocrinol. Metab. 89, 5415–5422 (2004)PubMed
39.
Zurück zum Zitat J. Bollerslev, S. Jansson, C.L. Mollerup et al. Medical observation, compared with parathyroidectomy, for asymptomatic primary hyperparathyroidism: a prospective, randomized trial. J. Clin. Endocrinol. Metab. 92, 1687–1692 (2007)PubMed J. Bollerslev, S. Jansson, C.L. Mollerup et al. Medical observation, compared with parathyroidectomy, for asymptomatic primary hyperparathyroidism: a prospective, randomized trial. J. Clin. Endocrinol. Metab. 92, 1687–1692 (2007)PubMed
40.
Zurück zum Zitat E. Ambrogini, F. Cetani, L. Cianferotti et al. Surgery or surveillance for mild asymptomatic primary hyperparathyroidism: a prospective, randomized clinical trial. J. Clin. Endocrinol. Metab.92, 3114–3121 (2007)PubMed E. Ambrogini, F. Cetani, L. Cianferotti et al. Surgery or surveillance for mild asymptomatic primary hyperparathyroidism: a prospective, randomized clinical trial. J. Clin. Endocrinol. Metab.92, 3114–3121 (2007)PubMed
41.
Zurück zum Zitat K. Zanocco, Z. Butt, D. Kaltman, D. Elaraj, D. Cella, J.L. Holl, C. Sturgeon, Improvement in patient-reported physical and mental health after parathyroidectomy for primary hyperparathyroidism. Surgery 158(3), 837–845 (2015)PubMed K. Zanocco, Z. Butt, D. Kaltman, D. Elaraj, D. Cella, J.L. Holl, C. Sturgeon, Improvement in patient-reported physical and mental health after parathyroidectomy for primary hyperparathyroidism. Surgery 158(3), 837–845 (2015)PubMed
42.
Zurück zum Zitat F. Goglia, Biological effects of 3,5 - Diiodotironine (T2). Biochemistry 70(2), 164–172 (2005)PubMed F. Goglia, Biological effects of 3,5 - Diiodotironine (T2). Biochemistry 70(2), 164–172 (2005)PubMed
43.
Zurück zum Zitat R. Senese, F. Cioffi, P. de Lange, F. Goglia, A. Lanni, Thyroid: biological actions of ‘nonclassical’ thyroid hormones. J. Endocrinol. 221, R1–R12 (2014)PubMed R. Senese, F. Cioffi, P. de Lange, F. Goglia, A. Lanni, Thyroid: biological actions of ‘nonclassical’ thyroid hormones. J. Endocrinol. 221, R1–R12 (2014)PubMed
44.
Zurück zum Zitat M.G. Castagna, M. Dentice, S. Cantara, R. Ambrosio, F. Maino, T. Porcelli et al. DIO2 Thr92Ala reduces deiodinase-2 activity and serum-T3 levels in thyroid-deficient patients. J. Clin. Endocrinol. Metab. 102, 1623–1630 (2017)PubMed M.G. Castagna, M. Dentice, S. Cantara, R. Ambrosio, F. Maino, T. Porcelli et al. DIO2 Thr92Ala reduces deiodinase-2 activity and serum-T3 levels in thyroid-deficient patients. J. Clin. Endocrinol. Metab. 102, 1623–1630 (2017)PubMed
45.
Zurück zum Zitat S. Jo, T.L. Fonseca, B.M.L.C. Bocco, G.W. Fernandes, E.A. McAninch, A.P. Bolin et al. Type 2 deiodinase polymorphism causes ER stress and hypothyroidism in the brain. J. Clin. Investig. 129, 230–245 (2019)PubMed S. Jo, T.L. Fonseca, B.M.L.C. Bocco, G.W. Fernandes, E.A. McAninch, A.P. Bolin et al. Type 2 deiodinase polymorphism causes ER stress and hypothyroidism in the brain. J. Clin. Investig. 129, 230–245 (2019)PubMed
46.
Zurück zum Zitat W.M. Wiersinga, L. Duntas, V. Fadeyev, B. Nygaard, M.P. Vanderpump, 2012 ETA guidelines: the use of L-T4 + L-T3 in the treatment of hypothyroidism. Eur. Thyroid J. 1, 55–71 (2012)PubMedPubMedCentral W.M. Wiersinga, L. Duntas, V. Fadeyev, B. Nygaard, M.P. Vanderpump, 2012 ETA guidelines: the use of L-T4 + L-T3 in the treatment of hypothyroidism. Eur. Thyroid J. 1, 55–71 (2012)PubMedPubMedCentral
47.
Zurück zum Zitat S.J. Peterson, A.R. Cappola, M.R. Castro, C.M. Dayan, A.P. Farwell, J.V. Hennessey et al. An online survey of hypothyroid patients demonstrates prominent dissatisfaction. Thyroid 28, 707–721 (2018)PubMedPubMedCentral S.J. Peterson, A.R. Cappola, M.R. Castro, C.M. Dayan, A.P. Farwell, J.V. Hennessey et al. An online survey of hypothyroid patients demonstrates prominent dissatisfaction. Thyroid 28, 707–721 (2018)PubMedPubMedCentral
48.
Zurück zum Zitat M. De Oliveira, L.S. Mathias, B.M. Rodrigues, B.G. Mariani, J.B. Graceli, M.T. De Sibio, R.M. Castro Olimpio, F.C. Fontes Moretto, I.C. Deprá, C.R. Nogueira, The roles of triiodothyronine and irisin in improving the lipid profile and directing the browning of human adipose subcutaneous cells. Mol. Cell. Endocrinol. 15, 506 (2020). https://doi.org/10.1016/j.mce.2020.110744CrossRef M. De Oliveira, L.S. Mathias, B.M. Rodrigues, B.G. Mariani, J.B. Graceli, M.T. De Sibio, R.M. Castro Olimpio, F.C. Fontes Moretto, I.C. Deprá, C.R. Nogueira, The roles of triiodothyronine and irisin in improving the lipid profile and directing the browning of human adipose subcutaneous cells. Mol. Cell. Endocrinol. 15, 506 (2020). https://​doi.​org/​10.​1016/​j.​mce.​2020.​110744CrossRef
49.
Zurück zum Zitat Biondi B., Bartalena L., Chiovato L., Lenzi A., Mariotti S., Pacini F., Pontecorvi A., Vitti P., Trimarchi F., Recommendations for treatment of hypothyroidism with levothyroxine and levotriiodothyronine: a 2016 position statement of the Italian Society of Endocrinology and the Italian Thyroid Association. J. Endocrinol. Investig. (2016). https://doi.org/10.1007/s40618-016-0511-z Biondi B., Bartalena L., Chiovato L., Lenzi A., Mariotti S., Pacini F., Pontecorvi A., Vitti P., Trimarchi F., Recommendations for treatment of hypothyroidism with levothyroxine and levotriiodothyronine: a 2016 position statement of the Italian Society of Endocrinology and the Italian Thyroid Association. J. Endocrinol. Investig. (2016). https://​doi.​org/​10.​1007/​s40618-016-0511-z
50.
Zurück zum Zitat Acuña-Castroviejo D., Escames G., Venegas G., Dìaz-Casado M.E., Lima-Cabello E., López L.C., Rosales-Corral S., Tan D.-X., Reiter R.J., Extrapineal melatonin: sources, regulation, and potential functions. Cell. Mol. Life Sci. (2014). https://doi.org/10.1007/s00018-014-1579-2 Acuña-Castroviejo D., Escames G., Venegas G., Dìaz-Casado M.E., Lima-Cabello E., López L.C., Rosales-Corral S., Tan D.-X., Reiter R.J., Extrapineal melatonin: sources, regulation, and potential functions. Cell. Mol. Life Sci. (2014). https://​doi.​org/​10.​1007/​s00018-014-1579-2
52.
Zurück zum Zitat E.T. Diniz et al. Primary hyperparathyroidism is associated with subclinical peripheral neural alterations. Endocr. Pract. 19, 219–225 (2013)PubMed E.T. Diniz et al. Primary hyperparathyroidism is associated with subclinical peripheral neural alterations. Endocr. Pract. 19, 219–225 (2013)PubMed
53.
Zurück zum Zitat G.B. Talpos et al. Randomized trial of parathyroidectomy in mild asymptomatic primary hyperparathyroidism: patient description and effects on the SF-36 health survey. Surgery. 128, 1013–1020 (2000)PubMed G.B. Talpos et al. Randomized trial of parathyroidectomy in mild asymptomatic primary hyperparathyroidism: patient description and effects on the SF-36 health survey. Surgery. 128, 1013–1020 (2000)PubMed
Metadaten
Titel
Chronic asthenia in patients who have undergone endocrine neck surgery
verfasst von
Gregorio Scerrino
Giuseppina Melfa
Daniela Lo Brutto
Sergio Mazzola
Alessandro Corigliano
Irene Vitale
Roberta Tutino
Giulia Rotolo
Giuseppina Orlando
Gianfranco Cocorullo
Publikationsdatum
07.08.2021
Verlag
Springer US
Erschienen in
Endocrine / Ausgabe 1/2022
Print ISSN: 1355-008X
Elektronische ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-021-02838-3

Weitere Artikel der Ausgabe 1/2022

Endocrine 1/2022 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.